1. Home
  2. NMRA vs NNBR Comparison

NMRA vs NNBR Comparison

Compare NMRA & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • NNBR
  • Stock Information
  • Founded
  • NMRA 2019
  • NNBR 1980
  • Country
  • NMRA United States
  • NNBR United States
  • Employees
  • NMRA N/A
  • NNBR N/A
  • Industry
  • NMRA
  • NNBR Industrial Machinery/Components
  • Sector
  • NMRA
  • NNBR Industrials
  • Exchange
  • NMRA Nasdaq
  • NNBR Nasdaq
  • Market Cap
  • NMRA 121.0M
  • NNBR 111.0M
  • IPO Year
  • NMRA 2023
  • NNBR 1994
  • Fundamental
  • Price
  • NMRA $0.77
  • NNBR $1.97
  • Analyst Decision
  • NMRA Buy
  • NNBR
  • Analyst Count
  • NMRA 8
  • NNBR 0
  • Target Price
  • NMRA $9.29
  • NNBR N/A
  • AVG Volume (30 Days)
  • NMRA 847.9K
  • NNBR 215.6K
  • Earning Date
  • NMRA 08-05-2025
  • NNBR 08-06-2025
  • Dividend Yield
  • NMRA N/A
  • NNBR N/A
  • EPS Growth
  • NMRA N/A
  • NNBR N/A
  • EPS
  • NMRA N/A
  • NNBR N/A
  • Revenue
  • NMRA N/A
  • NNBR $448,780,000.00
  • Revenue This Year
  • NMRA N/A
  • NNBR N/A
  • Revenue Next Year
  • NMRA N/A
  • NNBR $4.96
  • P/E Ratio
  • NMRA N/A
  • NNBR N/A
  • Revenue Growth
  • NMRA N/A
  • NNBR N/A
  • 52 Week Low
  • NMRA $0.61
  • NNBR $1.58
  • 52 Week High
  • NMRA $17.19
  • NNBR $4.67
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 45.74
  • NNBR 47.29
  • Support Level
  • NMRA $0.81
  • NNBR $1.82
  • Resistance Level
  • NMRA $1.34
  • NNBR $2.10
  • Average True Range (ATR)
  • NMRA 0.10
  • NNBR 0.15
  • MACD
  • NMRA -0.01
  • NNBR -0.02
  • Stochastic Oscillator
  • NMRA 12.55
  • NNBR 26.79

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.

Share on Social Networks: